| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 50, 206-208, Copyright © 1980 by Endocrine Society
ARTICLES |
JJ Van Wyk, ME Svoboda and LE Underwood
Somatomedin-C (SM-C) and insulin-like growth factor I (IGF-I) produced identical curves of competition in a RIA for SM-C, and in placental cell membrane receptor assays for SM-C and insulin. Somatomedin-A (SM- A), insulin-like growth factor II (IGF-II) and two forms of multiplication stimulating activity (MSA) were less than 5% as potent as SM-C/IGF-I in the RIA and less than 50% that of SM-C/IGFi in the SM- C receptor assay. In the insulin receptor assay, IGF-II and MSA III-2 were much more potent than SM-C/IGF-I. The present data suggest that SM- C and IGF-I are functionally identical substances.
This article has been cited by other articles:
![]() |
T. D. Etherton Somatotropic function: The somatomedin hypothesis revisited J Anim Sci, January 1, 2004; 82(13_suppl): E239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Juskevich and C. Guyer Bovine growth hormone: human food safety evaluation Science, August 24, 1990; 249(4971): 875 - 884. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |